Login Register Cart 0
Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Role of the Heterocycles to Design Anti-Cancer Agents

Author(s): Bubun Banerjee

Volume 22, Issue 19, 2022

Published on: 30 September, 2022

Page: [3194 - 3195] Pages: 2

DOI: 10.2174/187152062219220930154651

« Previous Next »
[1]
Tacar, O.; Sriamornsak, P.; Dass, C.R. Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J. Pharm. Pharmacol., 2012, 65, 157-170.
[2]
Oun, R.; Moussa, Y.E.; Wheate, N.J. The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Trans., 2018, 47, 6645-6653.
[3]
Nussbaumer, S.; Bonnabry, P.; Veuthey, J-L.; Fleury-Souverain, S. Analysis of anticancer drugs: A review. Talanta, 2011, 85, 2265-2289.
[4]
Drugs & Medications A-Z. Available from. https://www.webmd.com/drugs/2/index
[5]
Singh, A.; Basu, A.; Sharma, A.; Priya, A.; Kaur, M.; Kaur, G.; Banerjee, B. Lawsone (2-hydroxy-1,4-naphthaquinone) derived anticancer agents. Phy. Sci. Rev, 2022. in press
[http://dx.doi.org/10.1515/psr-2021-0043]
[6]
Noole, V.; Krishna, T.; Godeshala, S.; Meraji, S.; Rege, K.; Reddy, C.K.; Kedika, B. Synthesis and biological evaluation of new 1,2,3-triazole derivatives of the chrysin flavonoid as anticancer agents. Anticancer. Agents Med. Chem., 2022, 22, 160-168.
[7]
Pathak, N.; Rathi, E.; Kumar, N.; Kini, S.G.; Rao, C.M. A review on anticancer potentials of benzothiazole derivatives. Mini Rev. Med. Chem., 2020, 20, 12-23.
[8]
Rashedy, A.A.E.; Aboul-Enein, H.Y. Hassan Benzimidazole derivatives as potential anticancer agents. Mini Rev. Med. Chem., 2013, 13, 399-407.
[9]
Montana, M.; Mathias, F.; Terme, T.; Vanelle, P. Antitumoral activity of quinoxaline derivatives: A systematic review. Eur. J. Med. Chem., 2019, 163, 136-147.
[10]
Prachayasittikul, S.; Pingaew, R.; Worachartcheewan, A.; Sinthupoom, N.; Prachayasittikul, V.; Ruchirawat, S.; Prachayasittikul, V. Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents. Mini Rev. Med. Chem., 2020, 20, 12-23.
[11]
Sidhu, J.S.; Singla, R. Mayank, Jaitak, V. Indole derivatives as anticancer agents for breast cancer therapy: A review. Anticancer. Agents Med. Chem., 2016, 16, 160-173.
[12]
Kaur, M.; Kaur, M.; Bandopadhyay, T.; Sharma, A.; Priya, A.; Singh, A.; Banerjee, B. Naturally occurring, natural product inspired and synthetic heterocyclic anti-cancer drugs. Phy. Sci. Rev., 2022. in press.
[http://dx.doi.org/10.1515/psr-2022-0003]
[13]
In book ‘Heterocyclic Anticancer Agents’. Eds. Banik, B.K., Banerjee, B. De Gryuter, Germany. Available from:
[http://dx.doi.org/10.1515/9783110735772]
[14]
Kumar, N.; Goel, N. Heterocyclic compounds: Importance in anticancer drug discovery. Anticancer. Agents Med. Chem., 2022, 22, 3196-3207.
[15]
Avula, S.K.; Das, B.; Csuk, R.; Al-Harrasi, A. Naturally occurring O-heterocycles as anticancer agents. Anticancer. Agents Med. Chem., 2022, 22, 3208-3218.
[16]
Majhi, S. Discovery, development and design of anthocyanins-inspired anticancer agents: A comprehensive review. Anticancer. Agents Med. Chem., 2022, 22, 3219-3238.
[17]
Brahmachari, G.; Banerjee, B. Facile and one-pot access to diverse and densely functionalized 2-amino-3-cyano-4H-pyrans and pyran-annulated heterocyclic scaffolds via an eco-friendly multicomponent reaction at room temperature using urea as a novel organo-catalyst. ACS Sustainable Chem. Eng., 2014, 2, 411-422.
[18]
Grover, P.; Bhardwaj, M.; Mehta, L.; Kapoor, G.; Chawla, P.A. Current developments in the pyran-based analogues as anticancer agents. Anticancer. Agents Med. Chem., 2022, 22, 3239-3268.
[19]
Sachdeva, H.; Saquib, M.; Tanwar, K. Design and development of triazole derivatives as prospective anticancer agents: A review. Anticancer. Agents Med. Chem., 2022, 22, 3269-3279.
[20]
Tyagi, Y.K. Geetanjali, Singh, R. Synthesis and anti-cancer applications of benzimidazole derivatives-recent studies. Anticancer. Agents Med. Chem., 2022, 22, 3280-3290.
[21]
Mir, R.H.; Mir, P.A. Mohi-ud-din, R.; Sabreen, S.; Maqbool, M.; Shah, A.J.; Shenmar, K.; Raza, S.N.; Pottoo, F.H. A comprehensive review on journey of pyrrole scaffold against multiple therapeutic targets. Anticancer. Agents Med. Chem., 2022, 22, 3291-3303.

Rights & Permissions Print Cite
Article Metrics
6
© 2024 Bentham Science Publishers | Privacy Policy